Search hospitals > Ohio > Canton

Gabrail Cancer Center

Claim this profile
Canton, Ohio 44718
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Solid Tumors
Conducts research for Pancreatic Cancer
328 reported clinical trials
7 medical researchers
Photo of Gabrail Cancer Center in CantonPhoto of Gabrail Cancer Center in CantonPhoto of Gabrail Cancer Center in Canton

Summary

Gabrail Cancer Center is a medical facility located in Canton, Ohio. This center is recognized for care of Lung Cancer, Cancer, Non-Small Cell Lung Cancer, Solid Tumors, Pancreatic Cancer and other specialties. Gabrail Cancer Center is involved with conducting 328 clinical trials across 286 conditions. There are 7 research doctors associated with this hospital, such as Nashat Gabrail, M.D., Gabrail Nashat, Ga Nashat, Doctorate, and Nashal Gabrail, MD.

Area of expertise

1Lung Cancer
Global Leader
Gabrail Cancer Center has run 81 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
metastatic
2Cancer
Global Leader
Gabrail Cancer Center has run 71 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 negative

Top PIs

Clinical Trials running at Gabrail Cancer Center

Cancer
Lung Cancer
Breast Cancer
Myelofibrosis
Solid Tumors
Pancreatic Cancer
Non-Small Cell Lung Cancer
Follicular Lymphoma
Lymphoma
Tumors
Image of trial facility.

Continued Darolutamide Treatment

for Cancer

This trial continues darolutamide treatment for patients who were part of a previous study and are believed to benefit from it. Darolutamide helps by blocking hormones that can make cancer cells grow. Patients will keep taking the same dosage and visit their doctors regularly. Darolutamide has been shown to slow cancer spread and improve survival in patients with nonmetastatic castration-resistant prostate cancer.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Bria-IMT + CPI

for Advanced Breast Cancer

This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Abemaciclib + Elacestrant

for Brain Metastasis from Breast Cancer

This trial tests a combination of two drugs, elacestrant and abemaciclib, in patients with a specific type of breast cancer. It aims to find the best dose and see how well it works for those whose cancer has spread to the brain. The drugs work by blocking signals that help cancer cells grow and divide. Abemaciclib is a drug that has been approved for the treatment of certain advanced breast cancers.
Recruiting1 award Phase 1 & 212 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Gabrail Cancer Center?
Where is Gabrail Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Gabrail Cancer Center accept?
What awards or recognition has Gabrail Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security